Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline for menstrual irregularity and laboratory findings in women with PCOS and hyperprolactinemia
IRCT2014121420086N2Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cabergoline in polycystic ovary syndrome (PCOS) and hyperprolactinemia, sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Menstrual irregularity and Laboratory findings. Started Jun 2012; status: completed.
02
Drugs
cabergoline
03
Conditions
polycystic ovary syndrome (PCOS)hyperprolactinemia
Beyond the preview
Go deeper on IRCT2014121420086N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014121420086N2.